![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe PROMO |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW
Minerva Endocrinologica 2020 December;45(4):376-80
DOI: 10.23736/S0391-1977.20.03390-8
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone
Martina CAPUZZO 1, Valeria DONNO 1, Antonio LA MARCA 1, 2 ✉
1 Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy; 2 Clinica EUGIN, Modena, Italy
The differential diagnosis of anovulatory disorders is actually based on serum gonadotrophin and estradiol levels. However, several other markers have been proposed. The purpose of this review was to underline the role of anti-Müllerian hormone (AMH) as a possible marker in differential diagnosis of the anovulatory diseases and its use as a predictive marker of prognosis. In this article we discuss clinical and experimental evidences actually existing in literature and we suggest new potential clinical application of AMH.
KEY WORDS: Anti-Müllerian hormone; Polycystic ovary syndrome; Amenorrhea; Menopause, premature